Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Flu Vaccine Distribution Guidance Needed For Suppliers, HIDA Says

Executive Summary

The Centers for Disease Control & Prevention should provide guidance to vaccine distributors on prioritizing purchasers of influenza vaccine when there is a shortage, the Health Industry Distributors Association suggested in comments to the General Accounting Office.

You may also be interested in...



Flu Vaccine Delay In 2001 Will Not Be As Extensive As Last Year - CDC

The influenza vaccine delay for the 2001 flu season is not expected to be as significant as the delay in 2000, CDC's National Immunization Program informed the Advisory Committee on Immunization Practices.

Flu Vaccine Delay In 2001 Will Not Be As Extensive As Last Year - CDC

The influenza vaccine delay for the 2001 flu season is not expected to be as significant as the delay in 2000, CDC's National Immunization Program informed the Advisory Committee on Immunization Practices.

Flu Vaccine Prices For Early Orders Up 50% To 100%, GAO Reports

Pre-orders of flu vaccine for the 2001-2002 season are averaging $4 to $5 per dose, representing a significant increase over early-order prices for previous flu seasons, a General Accounting Office report on the influenza vaccine supply says.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel